Cleared Abbreviated

K030102 - ADVIA CENTAUR AND ACS:180 LIQUID CARDIA...

K030102 is an FDA 510(k) clearance for ADVIA CENTAUR AND ACS:180 LIQUID CARDIA..., manufactured by Bayer Healthcare, LLC. The device is a Class 1 Chemistry device with product code JJT cleared through the Abbreviated 510(k) pathway after a 14-day FDA review.

K030102 · Bayer Healthcare, LLC · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2003
Decision
14d
Days
Class 1
Risk

K030102 is an FDA 510(k) clearance for the ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3. Classified as Enzyme Controls (assayed And Unassayed) (product code JJT), Class I - General Controls.

Submitted by Bayer Healthcare, LLC (Tarrytown, US). The FDA issued a Cleared decision on January 24, 2003 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Bayer Healthcare, LLC devices

FDA 510(k) Submission Details - K030102

510(k) Number K030102 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 10, 2003
Decision Date January 24, 2003
Days to Decision 14 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 88d · This submission: 14d
Pathway characteristics
Standards-based clearance path.

JJT Device Classification - Class 1, General Controls

Product Code JJT Enzyme Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJT Enzyme Controls (assayed And Unassayed)

All 70
Devices cleared under the same product code (JJT) and FDA review panel - the closest regulatory comparables to K030102.
MODIFICATION TO QUANTIMETRIX CARDIASURE CARDIAC MARKER
K062751 · Quantimetrix Corp. · Oct 2006
CLINIQA LIQUID QC CARDIAC MARKER CONTROL LEVELS 1, 2 & 3, TRI-LEVEL
K030768 · Cliniqa Corporation · Mar 2003
LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1, 2, 3, AND TRILEVEL
K021498 · Bio-Rad · May 2002
LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1,2,3, MODELS 646,647,648
K012656 · Bio-Rad · Sep 2001
CARDIASURE CARDIAC MARKERS CONTROL
K993723 · Quantimetrix Corp. · Nov 1999
CARDIOIMMUNE CARDIAC MARKER CONTROL LEVELS 1,2, AND 3
K992430 · Medical Analysis Systems, Inc. · Aug 1999